List of Anterios patents

List of Anterios patents

List of Amazon patents

List of Mojo Mobility patents

List of Lohocla Research Corporation patents

CEOs of encryption software companies

Customer relationship management (CRM) venture capital investors

Patents where

Current Assignee

Name

is

Anterios

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10285941 Amphiphilic entity nanoparticles	Patent 10285941 was granted and assigned to Anterios on May, 2019 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	10285941	May 14, 2019
	‌ US Patent 9486409 Peptide nanoparticles and uses therefor	Patent 9486409 was granted and assigned to Anterios on November, 2016 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	9486409	November 8, 2016
	‌ US Patent 10016451 Nucleic acid nanoparticles and uses therefor	Patent 10016451 was granted and assigned to Anterios on July, 2018 by the United States Patent and Trademark Office.		Anterios		United States Patent and Trademark Office	10016451	July 10, 2018
	‌ US Patent 10905637 Peptide nanoparticles and uses therefor	Patent 10905637 was granted and assigned to Anterios on February, 2021 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	10905637	February 2, 2021
	‌ US Patent 10758485 Amphiphilic entity nanoparticles	Patent 10758485 was granted and assigned to Anterios on September, 2020 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	10758485	September 1, 2020
	‌ US Patent 9649266 Methods to treat, prevent, and improve skin conditions	Patent 9649266 was granted and assigned to Anterios on May, 2017 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	9649266	May 16, 2017
	‌ US Patent 10485855 Demonstrable efficacy across or within patient populations	Patent 10485855 was granted and assigned to Anterios on November, 2019 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	10485855	November 26, 2019
	‌ US Patent 9724299 Amphiphilic entity nanoparticles	Patent 9724299 was granted and assigned to Anterios on August, 2017 by the United States Patent and Trademark Office.	Anterios	Anterios		United States Patent and Trademark Office	9724299	August 8, 2017
	‌ US Patent 8658391 Assessment of the effects of topical administration of chemodenervating pharmaceuticals	Patent 8658391 was granted and assigned to Anterios on February, 2014 by the United States Patent and Trademark Office.		Anterios		United States Patent and Trademark Office	8658391	February 25, 2014

9 results

0 selected

9 results

0 selected